Explore the world of scleroderma clinical treatment trials in this informative 31-minute conference talk from the 2022 National Scleroderma Foundation Education Conference. Gain valuable insights into the phases of clinical trials and deepen your understanding of scleroderma lung disease, particularly interstitial lung disease (ILD). Learn about Nintedanib (Ofev®) as a treatment option for scleroderma lung complications. Discover the motivations behind volunteering for clinical trials and get information on the currently recruiting BRAVOS Study. This presentation provides essential knowledge for individuals considering participation in scleroderma clinical trials, helping them make informed decisions about their treatment options.